<DOC>
	<DOCNO>NCT00756652</DOCNO>
	<brief_summary>In November 2006 , U.S. Food Drug Administration ( FDA ) approve Mentor 's MemoryGel silicone gel-filled breast implant use woman undergo primary revisional breast augmentation primary revisional breast reconstruction surgery . This postapproval study intend satisfy one element FDA 's postapproval monitoring requirement . In January 2015 , FDA approve protocol amendment limit scope data collection study collection secondary procedure/reoperation data MemoryGel participant .</brief_summary>
	<brief_title>Mentor MemoryGel Post-Approval Study</brief_title>
	<detailed_description />
	<criteria>1 . Female , age 18 year old ( 22 old breast augmentation patient ) 2 . U.S. resident 1 . If saline participant , current past , unilateral bilateral , silicone breast implant 2 . Active infection anywhere body 3 . Existing breast cancer precancer breast without adequate treatment condition 4 . Currently pregnant nursing</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>